The purpose of this study was to compare chondral defects repair with in vitro and in vivo differentiated mesenchymal stem cells (MSCs). A novel PLGA-gelatin/chondroitin/hyaluronate (PLGA-GCH) hybrid scaffold with transforming growth factor-β1 (TGF-β1)-impregnated microspheres (MS-TGF) was fabricated to mimic the extracellular matrix. MS-TGF showed an initial burst release (22.5%) and a subsequent moderate one that achieved 85.1% on day 21. MSCs seeded on PLGA-GCH/MS-TGF or PLGA-GCH were incubated in vitro and showed that PLGA-GCH/MS-TGF significantly augmented proliferation of MSCs and glycosaminoglycan synthesis compared with PLGA-GCH. Then MSCs seeded on PLGA-GCH/MS-TGF were implanted and differentiated in vivo to repair chondral defect on the right knee of rabbit (in vivo differentiation repair group), while the contralateral defect was repaired with in vitro differentiated MSCs seeded on PLGA-GCH (in vitro differentiation repair group). The histology observation demonstrated that in vivo differentiation repair showed better chondrocyte morphology, integration, and subchondral bone formation compared with in vitro differentiation repair 12 and 24 weeks postoperatively, although there was no significant difference after 6 weeks. The histology grading score comparison also demonstrated the same results. The present study implies that in vivo differentiation induced by PLGA-GCH/MS-TGF and the host microenviroment could keep chondral phenotype and enhance repair. It might serve as another way to induce and expand seed cells in cartilage tissue engineering.
INTRODUCTION
The use of mesenchymal stem cells (MSCs) for cartilage tissue engineering has been investigated widely. Although the regenerated cartilage was impressive, the re-Articular cartilage can absorb impact forces, transfer load to subchondral bone, and provide extraordinarily sults were inconsistent, ranging from fibrous tissue to hyaline cartilage (12, 14, 15) . The repair did not usually efficient lubrication. However, once damaged, it has limited capacity to repair by itself. Thus, chondral injur-reconstitute sustainable cartilage and deteriorated with time. There were also arguments on the efficiency of ies can lead to progressive deterioration and eventually osteoarthritis (24, 32) . Current surgical treatments vary differentiation, integrity of repaired tissue, and the durability of regenerated cartilage. The reasons for this vari-from shaving the articular surface, perforating the subchondral bone, and filling the defects with osteochondral ability were attributed to scaffolds and cytokines supplied to keep phenotype or chondrogenesis (9, 17) . graft to artificial joint replacement. Although positive outcomes, such as reduced pain or partially restored Poly(lactic-co-glycolic acid) (PLGA) copolymer is one of a few synthetic materials that have been used in function, are reported, few surgical procedures have yielded satisfactory results. Additional concerns include clinical applications approved by the FDA. However, the hydrophobicity and topographical features of the risks of further damage, donor site morbidity, and pathogen transfer (2, 10, 25) . Recently, tissue engineering has conventional form limited adhesion, proliferation, and subsequent functions of various cells like osteoblasts ushered in new methodologies, which may offer many advantages over the current treatment strategies (18) . and chondrocytes as well as MSCs (20) . Recently, at-824 FAN ET AL.
tempts to modify the surface of PLGA scaffold were min, 10 ml of chilled acetone (4°C) was added. After 6 min, microspheres were collected and washed with ace-explored (26, 37) . Because collagen, chondroitin sulfate (CS), and hyaluronate were reported to play critical roles tone to remove residual olive oil. They were then crosslinked by incubation in 10 mM glutaraldehyde (GA) in keeping chondral phenotype (36) , we successfully fabricated PLGA-gelatin/chondroitin/hyaluronate (PLGA-(Sigma Co.) at 4°C for 24 h and washed with ddH 2 O, then lyophilized overnight. The qualities of separate GCH) hybrid scaffold for tissue engineered cartilage. Then in vitro differentiated MSCs seeded on PLGA-batchs of microspheres were effectively controlled. Dried microspheres were loaded with TGF-β1 (4 ng/ GCH repaired the whole thickness cartilage defects in rabbits (5) . However, some cases showed degenerated mg) by swelling in aqueous TGF-β1 solution at pH 7.4 according to a previous method (23) . The morphology chondrocytes and irregular surface. Even histological grading score worsened with time. There were two main of MS-TGF was examined under scanning electron microscopy (SEM) (Hitachi Ltd., Tokyo) and the size dis-reasons: 1) cytokines supplied from host tissue at the site of the chondral defect were insufficient to keep phe-tribution was determined with PC Image analysis system (Leica Ltd., Germany). MS-TGF (10 mg, n = 6) was dis-notype and chondrogenesis after implantation (19) , and 2) the dedifferentiation of differentiated cells seemed persed into 5 ml of PBS (pH 7.4) and placed in a shaking water bath at 37°C, 135 rpm. After 0.5, 1, 2, 3, 5, 7, unavoidable during multiplication in vitro (11) . Thus, cytokine supply and in vivo differentiation methods 10, 13, 17, and 21 days, the supernatant was collected for TGF-β1 analysis by an enzyme-linked immunosor-were needed, which until now had been lacking.
Microspheres could act as a vehicle for controlled re-bent assay (ELISA) kit (R&D Systems, Inc., Minneapolis, MN). lease. Recent results suggested that transforming growth factor-β1 (TGF-β1)-impregnated microspheres (MS-Hybrid Scaffold Fabrication and Incorporation TGF) were able to enhance chondrocyte proliferation With MS-TGF and matrix production (21, 22) . Our previous study also showed MS-TGF promoted proliferation and chondral
The hybrid scaffold was prepared by forming GCH microsponges in the openings of a macroporous PLGA differentiation of MSCs in vitro (6) . Therefore, we hypothesized the controlled release of TGF-β1 from MS-frame. PLGA (50:50 wt% PLA:PGA; 12,000-16,500 kDa; Polysciences Inc.) copolymer frame was fabricated TGF, the biochemical and biomechanical properties of PLGA-GCH, as well as the microenvironment of host via low temperature deposition (LDM) as we reported previously (33) . The ratio of gelatin, chondroitin-6-sulfate, tissue could result an in vivo differentiation that could keep chondral phenotype and enhance cartilage repair and sodium hyaluronate for GCH was according to a previous report (3) . Briefly, gelatin powder (0.5 g, more significantly compared with in vitro differentiation.
Sigma Co.), chondroitin-6-sulfate (CS) powder (0.1 g, Sigma Co.), and sodium hyaluronate (5 mg; CP Freda In order to prove this hypothesis, the study was designed: 1) to fabricate and characterize the PLGA-GCH Pharmacy Co., China) was mixed with 7 ml of ddH 2 O. The PLGA frame was immersed in the solution under hybrid scaffold with MS-TGF (PLGA-GCH/MS-TGF), 2) to observe proliferation of MSCs and glycosaminog-mild vacuum and cross-linked for 2-3 min at 25°C by using 2 ml of 1% 1-ethyml-3-(3-dimethylaminopropyl)-lycan (GAG) synthesis on PLGA-GCH/MS-TGF, and 3) to repair chondral defects with MSCs seeded on PLGA-carbodiimide (EDAC) (Sigma Co.). Then it was kept at −20°C for 1 h to end cross-linking and frozen at −80°C GCH/MS-TGF or in vitro differentiated MSCs seeded on PLGA-GCH. The purpose of the current research was for 1 h before lyophilization. The freeze-dried hybrid scaffold was re-cross-linked for 24 h at room tempera-to find whether in vivo differentiation could keep chondral phenotype and enhance cartilage regeneration. ture using 10 ml of 0.2% EDAC and washed several times to remove the residual carbodiimide until the ma-MATERIALS AND METHODS trix pH returned to physiologic range (7.0-7.4) (5).
MS-TGF Fabrication and Release Studies
Then the scaffold was lyophilized for 72 h to obtain the PLGA-GCH hybrid scaffold. The sections of scaffold Gelatin microspheres were fabricated according to previous reports (6, 30) . Briefly, 1.1 g acidic gelatin (n = 7) were used for 2D evaluation by a stereomicroscope. On average, 200 pores were assessed for each (Sigma Co., St. Louis, MO) with an isoelectric point (IEP) of 5.0 was dissolved in 7 ml of double-distilled sample to get the mean pore size, and the mean porosity was assessed according to previous method (29) . The water (ddH 2 O) by mixing and heating (53°C). The aqueous gelatin solution was added dropwise to 30 ml of hybrid scaffold was prepared in cylinder shape (3 mm in thickness and 4 mm in diameter). MS-TGF (0.2 mg) olive oil and 0.2 ml of Tween 80 (Sigma Co.) while stirring at 500 rpm. The temperature of emulsion was dispersed in 90% aqueous ethanol (100 µl) was carefully incorporated into each scaffold and immediately lyophi-then decreased to ϳ0°C with constant stirring. After 12 lized. The amount of TGF-β1 per scaffold was 0.8 ng.
uant was measured. The results obtained were expressed as cpm/scaffold. It was observed by SEM and then sterilized with ethylene oxide for implantation.
Full-Thickness Cartilage Defects Repair Mechanical Testing
The expanded MSCs from the same rabbit were then cultured in different media for implantation. In group A, Cylindrical scaffolds (n = 7) were used for compressive testing. Compressive testing to failure was con-cells were cultured only in basal medium (DMEM, 10% FCS, 100 U/ml penicillin G, 100 ng/ml streptomycin). ducted using an Instron mechanical testing machine (Instron model 5544, Canton, MA) with a crosshead speed
In group B, TGF-β1 (6 ng/ml) was added to serum-free medium (DMEM, 100 U/ml penicillin G, 100 ng/ml of 3 mm/min at ambient temperature and humidity. Compressive modulus and maximum compressive strength streptomycin, 2 µg/ml insulin, 32 µg/ml transferring, 100 µg/ml pyruvic acid, 10 −7 M dexamethasone) to in-of scaffolds were determined using Merlin software associated with the Instron machine.
duce chondral differentiation of MSCs in vitro. Seven days later, cells were stained immunohistochemically Isolation and Expansion of MSCs with collagen type II, S-100 protein, and toluidine blue to test chondrogenic differentiation as in our previous Mature New Zealand White rabbits (12 weeks old, 2.5-3 kg, n = 30) were anesthetized. According to previ-report (4). The results indicated that MSCs were not chondral induction in group A (negative staining) but ous methods bone marrow from the tibia was obtained and mononuclear cells were separated by centrifugation were in group B (light positive staining). The staining became much darker in group B after 2 weeks. in a Ficoll-Hypaque gradient (Sigma Co.), suspended in Dulbecco's modified Eagle' medium (DMEM) contain-Full-thickness defect (thickness: 3 mm; diameter: 4 mm) was created through the articular cartilage and sub-ing 20% fetal bovine serum (FCS) (HyClone, Logan, UT), and seeded at a concentration of 1 × 10 6 cells/cm 2 chondral bone of patellar groove in the above mentioned 30 rabbits using an electric drill equipped with a 4-mm-(13). Cultures were maintained at 37°C in an incubator containing 5% carbon dioxide. When the adherent cells diameter drill bit. Autologous MSCs (1 × 10 7 , passage 3) from group A were loaded on PLGA-GCH/MS-TGF reached subconfluence they were freed from the dish with 0.25% trypsin and subcultured for implantation. and the same number of cells from group B were loaded on PLGA-GCH, and then cultured for 12 h in vitro for MSCs Proliferation and GAG Synthesis adhesion. Then MSCs seeded on PLGA-GCH/MS-TGF were implanted and differentiated in vivo to repair the The MSCs (passage 3) were seeded on PLGA-GCH or PLGA-GCH/MS-TGF (n = 7; thickness: 3 mm; diam-chondral defect on the right knee of the rabbit (in vivo differentiation repair group), while the contralateral de-eter: 4 mm) at a cell density of 1.0 × 10 7 cells/scaffold using a syringe under mild negative pressure and then fect was repaired with in vitro differentiated MSCs seeded on PLGA-GCH (in vitro differentiation repair incubated at 37°C, 5% CO 2 for 3 h. DMEM (1.5 ml) containing 10% FCS and antibiotics (100 U/ml penicil-group). An additional five MSCs/PLGA-GCH/MS-TGF samples were prepared to observe the cellular adherence lin G and 100 ng/ml streptomycin) was then added to each well and incubation continued for 24 h. They were with SEM. Fifteen additional age-matched rabbits were used as empty control without treatment to defects on then placed in new culture plates in order to remove the lost cells on the bottom of the wells. On 1, 3, 6, 12, 18, both knees. All rabbits were allowed to move freely after surgery without plaster immobilization. The com-and 24 days they were collected to assay cell proliferation and GAG content. Thirty rabbits were used as experiment groups (30 knees treated with in vivo differentiation repair and 30 A 200-µl aliquot of papain digest was assayed for DNA content using the fluorescent dye Hoechst 33258. A 200-knees with in vitro differentiation repair) and 15 additional rabbits (30 knees) were used as empty control. µl aliquot of papain digest was assayed for thymidine uptake using a β-scintillation counter (Wallac, Turku, Samples were harvested 6, 12, and 24 weeks postoperatively. The distal femurs were removed and fixed in 4% Finland). A 500-µl aliquot was applied to Sephadex G-25 chromatography gel in a PD-10 column (Pharmacia paraformaldehyde, decalcified in 10% EDTA and embedded in paraffin, sagittally sectioned at 10 µm thick-Biosystems, Piscataway, NJ) and radioactivity in the el-ness, and stained with hematoxylin/eosin (H&E) stain-PLGA scaffold was 500 µm in size with highly interconnective morphology (Fig. 2B ). GCH formed micro-ing. The repair tissue was graded with a modified histological scale (27) . The scale included two catego-sponges in the openings of the macroporous PLGA frame. The cross-sectional morphology of PLGA-GCH ries. The first category evaluated surface layer repair based on three parameters: cell morphology and matrix showed porous microstructure with a high degree of interconnectivity and the porosity was 74% (Fig. 2C ). The staining graded from 0 to 8 points, surface regularity graded from 0 to 3, and integration of donor with host pores of GCH were fairly uniform and round shaped with a diameter 210 ± 40 µm. MS-TGF was also incor-adjacent cartilage graded from 0 to 2. The second category evaluated filling and remodeling of the defect porated into PLGA-GCH hybrid scaffold (Fig. 2D) . The magnified view demonstrated MS-TGF (or its aggre-based on two parameters: filling of defect graded from 0 to 4 and reconstitution of subchondral bone and osseous gates) was well distributed on the inner surface of the hybrid scaffold ( Fig. 2E ). After 12-h culture the MSCs connection graded from 0 to 3. The results were evaluated, according to the grading scale, by three individuals were entrapped in the microsponges of PLGA-GCH/ MS-TGF scaffold and showed uniform distribution ( , it showed a much more significant increase after TGF-β1 (IEP 9.5) is positively charged and forms a po-12 days (p < 0.05) ( Fig. 3 ). Both two groups had inlyionic complex with negatively charged acidic gelatin creasing thymidine uptake up to 24 days. But thymidine (IEP 5.0) (34) . The loading efficiency of TGF-β1 was uptake of the PLGA-GCH/MS-TGF group was signifi-4.0 ng/mg. The release of TGF-β1 from microspheres cantly higher on day 12, 18, and 24 (p < 0.05) ( Fig. 4 ). was in a biphasic fashion characterized by a fast release GAG synthesis was also found significantly increased on day 1 and slower release in the following days. The on day 6, 12, 18, and 24 in the PLGA-GCH/MS-TGF cumulative release was 22.5% initially and reached plagroup (p < 0.05) (Figs. 5 and 6). teau 3 days later, then finally reached 85.1% by day 21 (Fig. 1) . The morphology of MS-TGF was spherical and
Repair of Cartilage Defects smooth without cracks or wrinkles ( Fig. 2A) . The diam-In gross observation both in vitro and in vivo differeter was 13.5 ± 3.2 µm with effective quality control. entiation repair groups showed regenerated transparent SEM observation showed the macropore dimension of cartilage-like tissue 6 weeks postoperatively, although the defects were not fully filled up. Twelve weeks later the in vivo differentiation repair group had smoother surface compared with the in vitro group. After 24 weeks both groups showed well-reconstituted surface and integration, although the in vivo differentiation repair showed more obvious hyaline cartilage and appeared smooth, tenacious, and ill-demarcated from host cartilage. Histology observation indicated chondrocytes from differentiated MSCs distributed extensively but aligned disorderly in both groups 6 weeks postoperatively. The surface zone had moderate staining while the deep layer dark staining, but poor integration (Fig. 7A,  B) . Twelve weeks later the newly formed cartilage from the in vivo differentiation repair group showed uniformly metachromatic staining. In addition, the subchondral bone gradually regenerated and chondrocytes were parallel to the joint surface in the upper layer and perpendicular in the deep layer. The thickness of regen- was good integration. Although the in vitro differentia-ganized in the deep layer compared with in vivo differentiation repair. Integration was also a little rough (Fig. tion repair group also showed reconstituted subchondral bone and hyaline cartilage, it was noteworthy that the 7C, D). Twenty-four weeks later in vivo differentiation repair demonstrated the comparable thickness and exten-regenerated cartilage was thinner. The middle or upper layer showed moderate staining and chondrocytes lost sively dark staining matrix. In addition, the subchondral bone and morphology of chondrocytes were even nor-their typical spheric morphology. The subchondral bone did not connect smoothly and chondrocytes were disor- Six and 12 weeks postoperatively the empty control group showed incomplete defect repair with newly formed fibrous tissue. After 24 weeks the results remained similar and the defects were filled up only with fibrous scar in the deep layer.
Histological Score of Repair Tissue
In comparison with the empty control group, the scores of the in vitro differentiation repair group were better (i.e., lower) after 6, 12, and 24 weeks (Table 1) . However, specimens did not show uniform results. The integration and subchondral bone were not well reconstituted after 24 weeks, which correlated with a previous report (19) . Chondrocytes also lost their typical morphology in the middle or upper layer in some cases. The scores of the in vivo differentiated group were significantly better than those of the in vitro differentiation repair group after 12 and 24 weeks, even though there The present study demonstrated the cartilage defects with time. The chondrocytes in the middle or upper were fully repaired by in vivo differentiated MSCs on layer lost their typical morphology and appeared dedif-PLGA-GCH/MS-TGF scaffold. The regenerated cartiferentiation with light or moderate staining. Especially lage was superior to in vitro differentiated MSCs repair, the level of subchondral bone was raised and integration as evidenced by better surface and subchondral bone. was also rough (Fig. 7E, F ).
The ideal scaffold was able to mimic the ECM biochemically and biomechanically, which was important to keep chondral phenotype. In our previous study, we successfully fabricated PLGA-GCH hybrid scaffold and repaired the cartilage defects in rabbits. Although the repair was good in most cases, the regenerated cartilage decreased its thickness and showed irregular surface or rough integration in some cases after 24 weeks (5) . Other studies also indicated the regenerated cartilage might deteriorate with time (1). Therefore, this study aimed to develop a new method to induce the differentiation in vivo for enhancing cartilage regeneration.
TGF-β1 belongs to the TGF super family and influences a broad range of cellular activities, including proliferation, differentiation, and ECM synthesis. It could induce chondral differentiation and inhibit the activity of matrix metalloproteinase to prevent cartilage degeneration. Although TGF-β1 is a powerful molecule to repair cartilage damage, intra-articular injection in high dose is known to induce chemotaxis and activation of inflam- The grading scale has two categories assigning a total score ranging from 0 (best) to 20 (worst); A-C for evaluation of surface layers, D and E for evaluation of the filling and remodeling of the defect. A: graded from 0 to 8; B: graded from 0 to 3; C: graded from 0 to 2; D: graded from 0 to 4, and E: graded from 0 to 3. Values are mean ± SD. was designed in this study. No adverse effects, such as to keep chondral phenotype. However, it poses several problems, such as possible toxicity of lipofection, com-sclerosis or osteophyte, were observed in the present study. Recent studies (21, 22) showed microspheres plex technique, and low transfection efficiency, which limited the future application in humans. Instead we now could preserve the cytokine's bioactivity and offer a means of controlled release, which facilitated the prolif-use MS-TGF to induce the chondral differentiation. The ECM-mimicking scaffold, the host microenvironment, eration of chondrocytes. In this study gelatin microspheres were fabricated by emulsified cold condensation and controlled release TGF-β1 could result in a better induction in vivo. In addition, it also made the process method and loaded with TGF-β1. Gelatin was chosen because it has many functional groups (glycine, proline, easier.
The PLGA-GCH/MS-TGF could distribute sufficient hydroxyproline, and other amino acids) and no antigenicity (3). The diameter was 13.5 ± 3.2 µm with effec-cells as well as provide enough cytokines. Thus, we stably loaded MSCs onto PLGA-GCH or PLGA-GCH/MS-tive quality control. Comparing with the pore size of the scaffold (210 ± 40 µm), gelatiin could not hinder cellu-TGF to observe the inductive effects of MS-TGF. Most cells were embedded, indicating a stable entrapment that lar adherence. Our previous research had demonstrated the cellular adhesion rate on the same scaffold reached resulted from modified PLGA surface by GCH. Although the DNA content was a little lower in the PLGA-87.5% (7) . Compared to porous GCH, PLGA-GCH/MS-TGF scaffold had compressive moduli and compressive GCH/MS-TGF group, there was no significant difference in groups on days 1, 3, and 6. But after 12 days it strengths in the range of the trabecular bone. These biomechanical properties could prevent scaffolds from col-increased significantly (Fig. 3) . The differentiation might slow the proliferation at the initial stage. [ 3 H]Tymidine lapsing after implantation, especially for whole-thickness cartilage defects. uptake also showed a significant increase in the PLGA-GCH/MS-TGF group on days 12, 18, and 24 (p < 0.05) Acid gelatin was anionic at pH 7.4, which allowed it to form ionic complexes with cationic TGF-β1. This (Fig. 4) . Besides proliferation, TGF-β1 was reported to enhance proteoglycan deposition. In this study PLGA-characteristic was beneficial to retain or accumulate biologically active molecules for their sustained release GCH/MS-TGF caused a significant increase in GAG production in vitro after 6 days ( Figs. 5 and 6) . Although from the gelatin matrix. In this study MS-TGF showed controlled release of TGF-β1 over 21 days with biphasic the effects of MS-TGF were only detected for 21 days in vitro, the later effects could be explained by the mod-model (i.e., an initial burst and following plateau level). The initial burst release appeared significant (22.5%) est mitotic property of gelatin, hyaluronate. They could maintain a round or polygonal morphology of differenti-and the cumulative release was 85.1% after 21 days, which correlated with other results (21, 22) . The initial ated MSCs but only underwent a modest degree of mitosis (3) . Although the chondroitin sulfate (CS) in the burst was due to the resorption of TGF-β1, which was not incorporated into the gelatin matrix. The subsequent scaffold promoted the secretion of proteoglycan and collagen type II, it inhibited mitosis (28) . Considering hydration and protein diffusion led to a linear release phase. Our previous study suggested the controlled re-these, the effects of PLGA-GCH/MS-TGF on chondrogenesis and proliferation were explained by the fact that lease profile was sufficient to induce chondral differentiation of MSCs in vitro (8) . Although the bioactivity of initially exposed CS shielded the proliferation by TGF-β1; however, repeated TGF-β1 stimulation within scaf-TGF-β1 from MS-TGF was not quantitatively confirmed in this study, results suggested its activity was fold overcame the interaction between MSCs and CS.
In the present study PLGA-GCH/MS-TGF was proved preserved during loading, which correlated with another study using the same method (16) . Although the ELISA to induce MSCs in vivo, which subsequently might promote remodeling and integration of regenerated carti-method used in this study detected only the proteins forming immune complexes by antibody-antigen recog-lage. Six weeks later there was no significant difference between in vivo and in vitro differentiation repair nition reactions, it might partially account for the maintenance of the bioactivity of TGF-β1.
groups. But after 12 weeks, especially 24 weeks, in vivo differentiation repair resulted in better surface zone and In usual cartilage tissue engineering applications, chondrocytes or in vitro differentiated MSCs were ex-continuous subchondral bone as well as good remodeling. As the reconstitution of subchondral bone and su-panded in monolayer to obtain sufficient cells. During this process, cells dedifferentiated and lost their pheno-perficial zone were prerequisites for the durable repair, it was likely that in vivo differentiation attributed to better type to some extent; produced less cartilage-specific matrix proteins, such as collagen type II; and behaved more chondral phenotype and prevented degeneration. The differentiation of MSCs was complicated and affected like a fibroblastic cell type, producing increased amounts of collagen type I (35). Over the last decades by various factors such as cytokines, stress, microenvironment, etc. Although the ideal environment for differ-transgenic MSCs expressing target cytokines were used 
